Lv423
690 积分 2025-02-20 加入
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
3天前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
3天前
已完结
The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
3天前
已完结
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
3天前
已完结
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
4天前
已完结
Immunotherapy and Radiation Therapy Sequencing in Breast Cancer: A Systematic Review
4天前
已完结
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas
4天前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
14天前
已完结
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
14天前
已完结
Phase I clinical trial of PD-1 knockout anti-MUC1 CAR-T cells in the treatment of patients with non-small cell lung cancer
16天前
已完结
皖公网安备34019202002308
